China
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
29.72
|
Dec. 31, 2023 | USD 4.49 | NA |
|
China |
|
2 |
3.71
|
Dec. 31, 2023 | USD 0.33 | NA |
|
China |
|
3 |
3.11
|
Dec. 31, 2023 | USD 0.52 | NA |
|
China |
|
4 |
3.01
|
Dec. 31, 2023 | USD 0.63 | NA |
|
China |
|
5 |
2.96
|
Dec. 31, 2023 | USD 1.31 | NA |
|
China |
|
6 |
2.66
|
Dec. 31, 2023 | USD 0.39 | NA |
|
China |
|
7 |
2.65
|
Dec. 31, 2023 | USD 1.56 | NA |
|
China |
|
8 |
2.24
|
Dec. 31, 2023 | USD 0.81 | NA |
|
China |
|
9 |
2.18
|
March 31, 2024 | USD 1.59 | NA |
|
China |
|
10 |
2.16
|
Dec. 31, 2023 | USD 0.41 | NA |
|
China |
|
11 |
2.01
|
Dec. 31, 2023 | USD 0.16 | NA |
|
China |
|
12 |
1.85
|
Dec. 31, 2023 | USD 0.76 | NA |
|
China |
|
13 |
1.81
|
Dec. 31, 2023 | USD 0.67 | NA |
|
China |
|
14 |
1.66
|
Dec. 31, 2023 | USD 0.20 | NA |
|
China |
|
15 |
1.64
|
Dec. 31, 2023 | USD 0.71 | NA |
|
China |
|
16 |
1.60
|
Dec. 31, 2023 | USD 2.25 | NA |
|
China |
|
17 |
1.58
|
Dec. 31, 2023 | USD 1.14 | NA |
|
China |
|
18 |
1.48
|
Dec. 31, 2023 | USD 1.13 | NA |
|
China |
|
19 |
1.37
|
Dec. 31, 2023 | USD 1.15 | NA |
|
China |
|
20 |
1.30
|
Dec. 31, 2023 | USD 0.59 | NA |
|
China |
|
21 |
1.28
|
Dec. 31, 2023 | USD 2.53 | NA |
|
China |
|
22 |
1.26
|
Dec. 31, 2023 | USD 1.32 | NA |
|
China |
|
23 |
1.25
|
Dec. 31, 2023 | USD 0.38 | NA |
|
China |
|
24 |
1.21
|
Dec. 31, 2023 | USD 1.57 | NA |
|
China |
|
25 |
1.19
|
Dec. 31, 2023 | USD 0.45 | NA |
|
China |
|
26 |
1.03
|
Dec. 31, 2023 | USD 2.59 | NA |
|
China |
|
27 |
0.99
|
Dec. 31, 2023 | USD 2.63 | NA |
|
China |
|
28 |
0.95
|
Dec. 31, 2023 | USD 1.74 | NA |
|
China |
|
29 |
0.94
|
Dec. 31, 2023 | USD 3.06 | NA |
|
China |
|
30 |
0.93
|
Dec. 31, 2023 | USD 0.96 | NA |
|
China |
|
31 |
0.89
|
Dec. 31, 2023 | USD 4.55 | NA |
|
China |
|
32 |
0.86
|
Dec. 31, 2023 | USD 1.02 | NA |
|
China |
|
33 |
0.85
|
Dec. 31, 2023 | USD 0.53 | NA |
|
China |
|
34 |
0.84
|
Dec. 31, 2023 | USD 1.46 | -0.02% |
|
China |
|
35 |
0.83
|
Dec. 31, 2023 | USD 0.37 | NA |
|
China |
|
36 |
0.80
|
Dec. 31, 2023 | USD 1.95 | NA |
|
China |
|
37 |
0.80
|
Dec. 31, 2023 | USD 0.30 | NA |
|
China |
|
38 |
0.79
|
Dec. 31, 2023 | USD 3.55 | NA |
|
China |
|
39 |
0.78
|
Dec. 31, 2023 | USD 0.72 | NA |
|
China |
|
40 |
0.75
|
Dec. 31, 2023 | USD 1.84 | NA |
|
China |
|
41 |
0.73
|
Dec. 31, 2023 | USD 2.04 | NA |
|
China |
|
42 |
0.70
|
Dec. 31, 2023 | USD 2.14 | NA |
|
China |
|
43 |
0.69
|
Dec. 31, 2023 | USD 0.97 | NA |
|
China |
|
44 |
0.69
|
Dec. 31, 2023 | USD 0.34 | NA |
|
China |
|
45 |
0.67
|
Dec. 31, 2023 | USD 2.42 | NA |
|
China |
|
46 |
0.66
|
Dec. 31, 2023 | USD 1.72 | NA |
|
China |
|
47 |
0.66
|
Dec. 31, 2023 | USD 2.34 | NA |
|
China |
|
48 |
0.65
|
Dec. 31, 2023 | USD 4.31 | NA |
|
China |
|
49 |
0.64
|
Dec. 31, 2023 | USD 7.68 | NA |
|
China |
|
50 |
0.63
|
Dec. 31, 2023 | USD 1.60 | NA |
|
China |
The Healthcare company in China with the highest Debt to Equity Ratio is Ascentage Pharma Group International (HKSE: 6855.HK) at 29.72.
The Healthcare company in China with the lowest Debt to Equity Ratio is Hunan Jingfeng Pharmaceutical Co.,Ltd. (Shenzhen Stock Exchange: 000908.SZ) at -12.00.
The top 10 Healthcare companies in China by Debt to Equity Ratio are Ascentage Pharma Group International, Shenzhen Neptunus Bioengineering Co., Ltd., Chongqing Sansheng Industrial Co.,Ltd., Genertec Universal Medical Group Company Limited, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, Strait Innovation Internet Co., Ltd., Hybio Pharmaceutical Co., Ltd., MicroPort Scientific Corporation, China Jo-Jo Drugstores, Inc. and Tech-Bank Food Co., Ltd..
The bottom 10 Healthcare companies in China by Debt to Equity Ratio are Hunan Jingfeng Pharmaceutical Co.,Ltd., Ji Yao Holding Group Co., Ltd., Sinocelltech Group Limited, Shenzhen Division Co.,Ltd., Zhejiang Xinguang Pharmaceutical Co., Ltd., Beijing Science Sun Pharmaceutical Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., Chongqing Pharscin Pharmaceutical Co., Ltd., Beijing Succeeder Technology Inc. and Chengdu Kanghong Pharmaceutical Group Co., Ltd.